Manivannan R
Excel College of Pharmacy, Komarapalayam, Tamil Nadu

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Impact of Hypertension and Hyperlipidemia Screening with Intervention During the Utilization of Antihypertensive and Antihyperlipidemic Drugs Madheswaran M; Parimalakrishnan S; Manivannan R
Journal of Global Pharma Technology Volume 12 Issue 03 (2020) March 2020
Publisher : Journal of Global Pharma Technology

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (411.87 KB)

Abstract

The aim of the present study is to estimate the impact of intervention provided on screening programme to the participants and physicians and also proposed to study the factors influencing the physicians during prescribing antihypertensive and/ or antilipidemic agents. The study design was a cohort intervention study done at community pharmacies at Tamil Nadu, India. This was carried out for two years and data were collected from the patient record and interview. A screening prgoramme was arranged to measure blood pressure and total cholesterol levels. The primary outcome of measures was the percentage of patients prescribed antihypertensive and/ or antihyperlipidemic agents for 6 months before and after the intervention. Data were collected from 946 (75.68%) of patients visited the identified community pharmacies. 90.6%  and 9.4%of patients were allotted to the control and intervention groups to initiate antihypertensive and/ or antihyperlipidemic agents. After the intervention, the prevalence of antihypertensive agents prescribed was observed high among the intervention group when compared with the control group as the prevalence of antihyperlipidemic prescription. The similar results for the incidence were also observed for the antihypertensive agents and antihyperlipidemic agent prescription, during the study period after the intervention. This present study showed that the intervention was effective for improving the prescription containing antihypertensive and antihyperlipidemic agents as a primary outcome among patients with high blood pressure and lipid levels.